Author Title [ Type(Desc)] Year
Filters: Author is Schechter, Tal  [Clear All Filters]
Journal Article
Truong, T.H., Pole, J.D., Bittencourt, H., Schechter, T., Cuvelier, G.D.E., Paulson, K., Rayar, M., Mitchell, D., Schultz, K.R., O'Shea, D., et al. (2019). Access to Hematopoietic Stem Cell Transplantation among Pediatric Patients with Acute Lymphoblastic Leukemia: A Population-based Analysis.Biol Blood Marrow Transplant.
Ansari, M., Uppugunduri, C.Rao S., Ferrari-Lacraz, S., Bittencourt, H., Gumy-Pause, F., Chalandon, Y., Tiercy, J.-M., Schechter, T., Gassas, A., Doyle, J.D., et al. (2013). The Clinical Relevance of Pre-Formed Anti-HLA and Anti-MICA Antibodies after Cord Blood Transplantation in Children.Plos One8, e72141.
Gassas, A., Ashraf, K., Zaidman, I., Ali, M., Krueger, J., Doyle, J., Schechter, T., and Leucht, S. (2014). Hematopoietic stem cell transplantation in infants.Pediatr Blood Cancer.
Harris, A.C., Young, R., Devine, S., Hogan, W.J., Ayuk, F., Bunworasate, U., Chanswangphuwana, C., Efebera, Y.A., Holler, E., Litzow, M., et al. (2015). International, multi-center standardization of acute graft-versus-host disease clinical data collection: a report from the MAGIC consortium.Biol Blood Marrow Transplant.
Papaz, T., Allen, U., Blydt-Hansen, T., Birk, P.E., Min, S., Hamiwka, L., Phan, V., Schechter, T., Wall, D.A., Urschel, S., et al. (2018). Pediatric Outcomes in Transplant: PersOnaliSing Immunosuppression To ImproVe Efficacy (POSITIVE Study): The Collaboration and Design of a National Transplant Precision Medicine Program.Transplant Direct4, e410.
Schechter, T., Naqvi, A., and Weitzman, S. (2014). Risk for complications in patients with hemophagocytic lymphohistiocytosis who undergo hematopoietic stem cell transplantation: myeloablative versus reduced-intensity conditioning regimens.Expert Rev Clin Immunol1-6.
Gassas, A., Krueger, J., Schechter, T., Zaidman, I., Asim, M., and Ali, M. (2016). Safety and Role of Gastrointestinal Endoscopy in the Management of Gastrointestinal Acute GVHD in Children After Hematopoietic Stem Cell Transplantation.J Pediatr Hematol Oncol.
Lazor, T., Pole, J.D., De Souza, C., Schechter, T., Grant, R., Davis, H., Duong, N., Stein, E., Cook, S., Tigelaar, L., et al. (2019). Severity, change over time and risk factors of anxiety in children with cancer depends on anxiety instrument used.Psychooncology.
Hutspardol, S., Essa, M., Richardson, S., Schechter, T., Ali, M., Krueger, J., Fujii, H., R Egeler, M., and Gassas, A. (2015). Significant transplant-related mortality from respiratory virus infections within the first 100 days in children post hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.
Chellapandian, D., Krueger, J., Schechter, T., Gassas, A., Weitzman, S., Naqvi, A., and Ali, M. (2015). Successful allogeneic hematopoietic stem cell transplantation in XIAP deficiency using reduced-intensity conditioning.Pediatr Blood Cancer.
Patrick, K., Ali, M., Richardson, S.E., Gassas, A., Egeler, M., Krueger, J., Lowry, J., Allen, U., and Schechter, T. (2015). The yield of monitoring for HSV and VZV viremia in pediatric hematopoietic stem cell transplant patients.Pediatr Transplant.